Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (73 ops.)
Latest filing published 01 Oct 2026 for Kymera Therapeutics, Inc., €347k.
Filing timeline
BuySaleNello Mainolfi
Insider track record
Disclosed buys
0
Disclosed sells
73
Signal history
Nello Mainolfi: trading record in brief
The filings of Nello Mainolfi are published on the day of the trade, as a median, and the record holds 128 filings at Kymera Therapeutics, Inc. between April 12, 2021 and October 1, 2026, with the title "Founder, President and Chief Executive Officer". The year 2021 gathers 68, against 19 in 2022, 3 in both 2023 and 2024, 15 in 2025 and 20 in 2026.
The 73 open-market sales add up to EUR 39.6 million, with a median of EUR 274,069. The largest are EUR 7,660,505 on December 8, 2025, EUR 5,198,515 on July 7, 2026 and EUR 1,591,608 on December 31, 2025. No purchase is on record, and the 55 option exercises are the only other type of entry in the record. Over the last 12 months, 30 filings were published, 21 of them sales.
At Kymera Therapeutics, Inc., 31 trades by Nello Mainolfi fall within 30 days of a trade by Bruce N. Jacobs, 26 for Jared Gollob and 25 for Bruce Booth, all in the same direction.
Companies and markets linked to Nello Mainolfi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations128 total
3,525 shares@ US$111.440.0042% mcap2.9% of flowCommon StockSEC:0001193125-26-410839:1
30,000 shares@ US$2.080.0007% mcap0.5% of flowCommon StockSEC:0001193125-26-410839:0
5,506 shares@ US$112.420.0066% mcap4.6% of flowCommon StockSEC:0001193125-26-410839:2
4,876 shares@ US$113.240.0059% mcap4.1% of flowCommon StockSEC:0001193125-26-410839:3
7,601 shares@ US$114.430.0093% mcap6.5% of flowCommon StockSEC:0001193125-26-410839:4
8,230 shares@ US$115.400.010% mcap7.1% of flowCommon StockSEC:0001193125-26-410839:5
262 shares@ US$116.120.0003% mcap0.2% of flowCommon StockSEC:0001193125-26-410839:6
50,000 shares@ US$2.080.0011% mcap1.0% of flowCommon StockSEC:0001193125-26-297817:0
50,000 shares@ US$119.000.064% mcap59.0% of flowCommon StockSEC:0001193125-26-297817:1
12,059 shares@ US$81.700.010% mcap9.6% of flowCommon StockSEC:0001193125-26-192146:2
30,000 shares@ US$2.080.0007% mcap0.6% of flowCommon StockSEC:0001193125-26-192146:0
17,005 shares@ US$80.740.014% mcap13.3% of flowCommon StockSEC:0001193125-26-192146:1
936 shares@ US$82.450.0008% mcap0.7% of flowCommon StockSEC:0001193125-26-192146:3
19,764 shares@ US$89.782.9% of flowCommon StockSEC:0001193125-26-072155:1
5,434 shares@ US$90.390.8% of flowCommon StockSEC:0001193125-26-072155:2
3,293 shares@ US$91.760.5% of flowCommon StockSEC:0001193125-26-072155:3
1,501 shares@ US$92.810.2% of flowCommon StockSEC:0001193125-26-072155:4
8 shares@ US$93.490.0% of flowCommon StockSEC:0001193125-26-072155:5
30,000 shares@ US$2.080.6% of flowCommon StockSEC:0001193125-26-072155:0
3,118 shares@ US$32.071.0% of flowCommon StockSEC:0001193125-26-004641:0
23,986 shares@ US$77.953.0% of flowCommon StockSEC:0001193125-25-338415:1
6,014 shares@ US$78.520.8% of flowCommon StockSEC:0001193125-25-338415:2
30,000 shares@ US$2.080.6% of flowCommon StockSEC:0001193125-25-338415:0
2,595 shares@ US$38.531.0% of flowCommon StockSEC:0001193125-25-323092:0
100,000 shares@ US$89.1714.6% of flowCommon StockSEC:0001193125-25-311504:1
25 of 128 declarations
